Table 1.
Demographic characteristic of enrolled patients.
| No SIBO (n = 156) |
SIBO (n = 68) | p | |
|---|---|---|---|
| Male (n, %) | 73 (46.8) | 36 (52.9) | 0.397 |
| Age ≥ 60 years (n, %) | 93 (59.6) | 55 (80.9) | 0.002 |
| BMI ≥ 22 kg/m2 (n, %) | 136 (87.2) | 52 (76.5) | 0.045 |
| Presence of IBS (n, %) | 75 (48.1) | 42 (61.8) | 0.059 |
| Type of IBS (n, %) | |||
| IBS-D | 23 (14.7) | 18 (26.5) | 0.037 |
| IBS-C | 13 (8.3) | 3 (4.4) | 0.295 |
| Mixed type IBS | 39 (25.0) | 21 (30.9) | 0.361 |
| Comorbidities (n, %) | |||
| T2DM | 28 (17.9) | 21 (30.9) | 0.036 |
| CHF | 36 (23.1) | 20 (29.4) | 0.314 |
| COPD | 16 (10.3) | 5 (7.5) | 0.513 |
| CRF | 7 (4.5) | 2 (2.9) | 0.588 |
| Solid tumor malignancy | 14 (9.0) | 4 (5.9) | 0.434 |
| History of drug intake (n, %) | |||
| PPIs | 38 (24.4) | 13 (19.1) | 0.390 |
| NSAIDs | 9 (5.8) | 2 (2.9) | 0.368 |
| Aspirin | 27 (17.3) | 15 (22.1) | 0.402 |
| Acenocumarone | 11 (7.1) | 7 (10.3) | 0.412 |
| H2-blockers | 2 (1.3) | 1 (1.5) | 0.910 |
| Antacids | 5 (3.2) | 1 (1.5) | 0.460 |
| Clinical reason for gastroscopy (n, %) | |||
| Dyspepsia | 94 (60.3) | 39 (57.4) | 0.684 |
| Anemia | 73 (46.8) | 36 (52.9) | 0.397 |
| Fever of unknown origin | 7 (4.5) | 2 (2.9) | 0.588 |
| Endoscopic findings (n, %) | |||
| Gastritis | 69 (44.2) | 25 (36.8) | 0.298 |
| Duodenal ulcer | 12 (7.7) | 8 (11.8) | 0.326 |
| Gastric ulcer | 2 (1.3) | 1 (1.5) | 0.910 |